Description

Description

Sita-Met XR 50/500mg Tablet is an extended-release fixed-dose combination medicine used in the treatment of type 2 diabetes mellitus. It combines Sitagliptin, a DPP-4 inhibitor, with an extended-release form of Metformin, allowing the medicine to release its active ingredients gradually over an extended period rather than all at once. This slow-release design is intended to provide steadier blood sugar control throughout the day while reducing the frequency of digestive discomfort that can sometimes accompany immediate-release Metformin formulations. Sita-Met XR is generally prescribed once daily, often in the evening with the main meal, making it a convenient option for patients who prefer a simplified once-a-day routine over multiple daily doses. The pack contains 14 tablets, typically supporting a two-week treatment course as guided by the prescribing doctor. Because the extended-release mechanism depends on the tablet’s intact structure, this medicine should always be used exactly as instructed by a qualified healthcare provider.

Ingredients

Each Sita-Met XR 50/500mg Tablet contains Sitagliptin 50mg combined with Metformin Hydrochloride 500mg in its extended-release form. Sitagliptin works by extending the activity of naturally occurring incretin hormones to support glucose-dependent insulin release, while the extended-release Metformin component is engineered within a special polymer matrix that controls the rate at which the medicine dissolves and is absorbed, allowing for a more gradual and sustained glucose-lowering effect. Additional inactive ingredients typically include hydroxypropyl methylcellulose (used to form the controlled-release matrix), microcrystalline cellulose, magnesium stearate, and a film coat that gives the tablet its final finish.

Dosage Form

This product is formulated as an extended-release (XR) film-coated oral tablet, specifically designed with a controlled-release matrix that allows the medicine to be absorbed slowly over several hours after intake. The tablets are packed in blister strips to protect them from moisture and light, preserving their controlled-release properties until the labelled expiry date.

Uses

Sita-Met XR 50/500mg Tablet is used for managing blood sugar levels in adults with type 2 diabetes mellitus who benefit from a once-daily combination therapy with a smoother release profile. The Sitagliptin component helps regulate insulin secretion after meals and limits unnecessary glucose production by the liver, while the extended-release Metformin component provides a steady reduction in hepatic glucose output and gradually improves the body’s sensitivity to insulin over an extended period. This formulation is often chosen for patients who experienced stomach-related discomfort with immediate-release Metformin combinations, or those who prefer the convenience of a single daily dose. As with other diabetes therapies, it is generally used alongside dietary control and regular physical activity to support long-term blood sugar management and reduce the risk of diabetes-related complications.

How to Use

Sita-Met XR 50/500mg Tablet should be taken exactly as prescribed by the doctor, typically once daily with the evening meal, to support its extended and gradual release throughout the following hours. Unlike standard tablets, this extended-release formulation must always be swallowed whole with a glass of water and should never be crushed, broken, or chewed, as doing so can disrupt the controlled-release mechanism and cause the medicine to be released too quickly. Patients may occasionally notice what appears to be a tablet-shaped residue in their stool; this is simply the empty, non-absorbable shell of the extended-release matrix after the medicine has been released, and is not a cause for concern. Doses should not be skipped or doubled, and any adjustment to the treatment plan should only be made in consultation with a doctor.

Side Effects

Sita-Met XR is generally associated with a somewhat gentler digestive tolerability profile compared to immediate-release combinations, though side effects can still occur. Commonly reported effects include mild nausea, occasional diarrhea, reduced appetite, or a metallic taste, usually linked to the Metformin component and often easing as the body adjusts. Effects related to the Sitagliptin component may include headache, sore throat, or symptoms similar to an upper respiratory infection. In rare but serious cases, symptoms of lactic acidosis (such as unusual muscle pain, rapid or difficult breathing, and unexplained fatigue), signs of pancreatitis, or allergic reactions like skin rash and swelling may occur and require urgent medical attention. Any severe, persistent, or concerning symptoms should be discussed with a doctor promptly.

Pregnancy & Breastfeeding

Sita-Met XR 50/500mg Tablet is generally not the preferred treatment during pregnancy, and it should only be used if a physician determines that the potential benefit outweighs any possible risk, as diabetes management during pregnancy is often handled through different treatment protocols. Women who are pregnant, planning to conceive, or currently breastfeeding should inform their doctor before starting or continuing this medicine so that a more suitable option can be considered if necessary. Since both active components may pass into breast milk to some extent, breastfeeding mothers should seek personalized medical advice before use.

Storage Instructions

Store Sita-Met XR 50/500mg Tablets in a cool, dry place away from direct sunlight, heat, and moisture, ideally at a temperature below 30°C. Keep the tablets in their original blister packaging until ready for use to protect the controlled-release coating, and store them securely out of the reach and sight of children and pets. Avoid storing the medicine in humid areas such as bathrooms, and do not freeze the tablets. Always check the expiry date before use, and dispose of any expired or unused tablets responsibly through a proper medicine disposal program rather than household trash or drains.

FAQS

Q1. What does “XR” mean in Sita-Met XR?
XR stands for extended-release, meaning the Metformin component is released gradually over time rather than all at once, allowing for once-daily dosing.

Q2. Can this tablet be crushed or split for easier swallowing?
No, it should always be swallowed whole, as crushing or splitting can interfere with the controlled-release mechanism and change how quickly the medicine is absorbed.

Q3. Is it normal to see something resembling the tablet in the stool?
Yes, this is simply the leftover shell of the extended-release matrix after the medicine has been absorbed, and it is considered a normal and harmless occurrence.

Q4. Does the extended-release formula cause fewer stomach side effects?
Many patients experience better digestive tolerability with extended-release Metformin compared to immediate-release versions, though individual responses can vary.

Q5. What is the best time of day to take this tablet?
It is commonly taken once daily with the evening meal, though the exact timing should follow the specific instructions given by the prescribing doctor.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.